The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis
Open accessAbstract
Rationale: In experimental models, lung fibrosis is dependent on transforming growth factor (TGF)-β signaling. TGF-β is secreted in a latent complex with its propeptide, and TGF-β activators release TGF-β from this complex. Because the integrin αvβ6 is a major TGF-β activator in the lung, inhibition of αvβ6-mediated TGF-β activation is a logical strategy to treat lung fibrosis. Objectives: To determine, by genetic and pharmacologic approaches, whether murine radiation-induced lung fibrosis is dependent on αvβ6. Methods: Wild-type mice, αvβ6-deficient (Itgb6−/−) mice, and mice heterozygous for a Tgfb1 mutation that eliminates integrin-mediated activation (Tgfb1+/RGE) were exposed to 14 Gy thoracic radiation. Some mice were treated with an anti-αvβ6 monoclonal antibody or a soluble TGF-β receptor fusion protein. αvβ6 expression was determined by immunohistochemistry. Fibrosis, inflammation, and gene expression patterns were assessed 20–32 weeks postirradiation. Measurements and Main Results: β6 Integrin expression increased within the alveolar epithelium 18 weeks postirradiation, just before onset of fibrosis. Itgb6−/− mice were completely protected from fibrosis, but not from late radiation-induced mortality. Anti-αvβ6 therapy (1–10 mg/kg/wk) prevented fibrosis, but only higher doses (6–10 mg/kg/wk) caused lung inflammation similar to that in Itgb6−/− mice. Tgfb1-haploinsufficient mice were also protected from fibrosis. Conclusions: αvβ6-Mediated TGF-β activation is required for radiation-induced lung fibrosis. Together with previous data, our results demonstrate a robust requirement for αvβ6 in distinct fibrosis models. Inhibition of αvβ6-mediated TGF-β activation is a promising new approach for antifibrosis therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pro-inflammatory cytokine IL-17A was identified as a key inducer of fibrosis in several different organ systems, including the lung, liver, kidney, heart, and skin109–114”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [113]
In the citing paper
“In addition, a monoclonal antibody targeting integrin αVβ6 has been shown to protect mice from radiation induced fibrosis (203).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Self-citationYu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,952
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2002) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,624
Self-citationA simplified method for the analysis of hydroxyproline in biological tissues
Reddy, G. K., & Enwemeka, C. S. (1996) · Clinical Biochemistry · doi:10.1016/0009-9120(96)00003-6 · Cited by 1,299
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V. M., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,176
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Datto, M., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., & Wang, X. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5545 · Cited by 945
The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP–dependent activation of TGF-β1
Mu, D., Cambier, S., Fjellbirkeland, L., Baron, J. L., Munger, J. S., Kawakatsu, H., Sheppard, D., Broaddus, V. C., & Nishimura, S. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109100 · Cited by 729
Self-citationA perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis
Rubin, P., Johnston, C. J., Williams, J. P., McDonald, S. A., & Finkelstein, J. N. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00095-g · Cited by 648
Research works printed but not linked: 4
- 2002, Cancer Res, 62, 3782
- 1989, Radiat Res, 119, 1
- 2005, Semin Oncol, 32, S42
- 2005, BJR Suppl, 27, 75
Cited by
Sorted by citations
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
Targeting the tumour stroma to improve cancer therapy
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0007-1 · Cited by 1,084
Fibroblasts and myofibroblasts in wound healing
Desmouliere, A., Darby, I. A., Laverdet, B., & Bonté, F. (2014) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s50046 · Cited by 1,039
Pathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 911
TGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800
The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers
Fernandez, I. E., & Eickelberg, O. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201203-023aw · Cited by 704
Radiation-induced fibrosis: mechanisms and implications for therapy
Straub, J. M., New, J., Hamilton, C. D., Lominska, C., Shnayder, Y., & Thomas, S. M. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1974-6 · Cited by 677
Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing
Margadant, C., & Sonnenberg, A. (2010) · The EMBO Reports · doi:10.1038/embor.2009.276 · Cited by 653
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 642
Developmental pathways in the pathogenesis of lung fibrosis
Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., Langhe, S. D., & Thannickal, V. J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 525
Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
Horan, G. S., Wood, S., Ona, V., Li, D. J., Lukashev, M. E., Weinreb, P. H., Simon, K. J., Hahm, K., Allaire, N. E., Rinaldi, N. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-805oc · Cited by 420
Self-citationMolecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 425
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
Role of Transforming Growth Factor–β in Airway Remodeling in Asthma
Halwani, R., Al‐Muhsen, S., Al-Jahdali, H. H., & Hamid, Q. A. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0027tr · Cited by 404
Emerging evidence for adapting radiotherapy to immunotherapy
Galluzzi, L., Aryankalayil, M. J., Coleman, C. N., & Formenti, S. C. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00782-x · Cited by 389
Self-citationCross Talk among TGF- Signaling Pathways, Integrins, and the Extracellular Matrix
Munger, J. S., & Sheppard, D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005017 · Cited by 372
Self-citationThe role of proteases in transforming growth factor-β activation
Jenkins, G. R. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.026 · Cited by 374
Transforming growth factor β—at the centre of systemic sclerosis
Lafyatis, R. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.137 · Cited by 348
TGF ‐β as a driver of fibrosis: physiological roles and therapeutic opportunities
Budi, E. H., Schaub, J. R., Decaris, M. L., Turner, S., & Derynck, R. (2021) · The Journal of Pathology · doi:10.1002/path.5680 · Cited by 310
Transforming growth factor β as a therapeutic target in systemic sclerosis
Varga, J., & Pasche, B. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.26 · Cited by 298
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
Sakai, N., & Tager, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.001 · Cited by 293
Radiation Pulmonary Toxicity: From Mechanisms to Management
Graves, P. R., Siddiqui, F., Anscher, M. S., & Movsas, B. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.01.010 · Cited by 282
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. R. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 278
TGF-β Activation and Lung Fibrosis
Tatler, A. L., & Jenkins, G. R. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201201-003aw · Cited by 272
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Cytlak, U., Dyer, D. P., Honeychurch, J., Williams, K. J., Travis, M. A., & Illidge, T. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00568-1 · Cited by 277
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Shi, X., Young, C. D., Zhou, H., & Wang, X. (2020) · Biomolecules · doi:10.3390/biom10121666 · Cited by 269
Integrins as Therapeutic Targets: Successes and Cancers
Raab-Westphal, S., Marshall, J. F., & Goodman, S. L. (2017) · Cancers · doi:10.3390/cancers9090110 · Cited by 251
Bouquet, F., Pal, A., Pilones, K. A., Demaria, S., Hann, B. C., Akhurst, R. J., Babb, J. S., Lonning, S. M., DeWyngaert, J. K., Formenti, S. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0544 · Cited by 247
Self-citationAhluwalia, N., Shea, B. S., & Tager, A. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0509pp · Cited by 237
Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis
Kliment, C. R., & Oury, T. D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.036 · Cited by 236
Knipe, R. S., Tager, A. M., & Liao, J. K. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009381 · Cited by 233
Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies
Rosenbloom, J., Castro, S. V., & Jimenez, S. A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-3-201002020-00007 · Cited by 230
Aluwihare, P., Mu, Z., Zhao, Z., Yu, D., Weinreb, P. H., Horan, G. S. B., Violette, S. M., & Munger, J. S. (2008) · Journal of Cell Science · doi:10.1242/jcs.035246 · Cited by 229
Self-citationIntegrin-mediated regulation of TGFβ in fibrosis
Henderson, N. C., & Sheppard, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.005 · Cited by 216
Schnittert, J., Bansal, R., Storm, G., & Prakash, J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.020 · Cited by 189
Current concepts in clinical radiation oncology
Orth, M., Lauber, K., Niyazi, M., Friedl, A. A., Li, M., Maihöfer, C., Schüttrumpf, L., Ernst, A., Niemoeller, O. M., & Belka, C. (2013) · Radiation and Environmental Biophysics · doi:10.1007/s00411-013-0497-2 · Cited by 186
Matrix Stiffness: the Conductor of Organ Fibrosis
Santos, A., & Lagares, D. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0710-z · Cited by 181
Désogère, P. A., Tapias, L. F., Hariri, L. P., Rotile, N. J., Rietz, T. A., Probst, C. K., Blasi, F., Day, H., Mino-Kenudson, M. A., Weinreb, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf4696 · Cited by 176
Self-citationStrategies for anti-fibrotic therapies
Rosenbloom, J., Mendoza, F. A., & Jiménez, S. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.007 · Cited by 174
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Nishimura, S. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090393 · Cited by 162
Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis
Bickelhaupt, S., Erbel, C., Timke, C., Wirkner, U., Dadrich, M., Flechsig, P., Tietz, A., Pföhler, J., Groß, W., Peschke, P., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw339 · Cited by 153
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
Wuyts, W. A., Antoniou, K. M., Borensztajn, K., Costabel, U., Cottin, V., Crestani, B., Grutters, J. C., Maher, T. M., Poletti, V., Richeldi, L., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70232-2 · Cited by 150
αv integrins: key regulators of tissue fibrosis
Conroy, K. P., Kitto, L. J., & Henderson, N. C. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2407-9 · Cited by 152
Watanabe, Y., Tsuchiya, A., & Terai, S. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0194 · Cited by 149
Biomechanics of TGFβ‐induced epithelial‐mesenchymal transition: implications for fibrosis and cancer
O’Connor, J. W., & Gomez, E. W. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-23 · Cited by 136
Role of Radiation-induced TGF-beta Signaling in Cancer Therapy
Dancea, H. C. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.06 · Cited by 124
Role of integrin-mediated TGFβ activation in the pathogenesis of pulmonary fibrosis
Goodwin, A. T., & Jenkins, G. R. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370849 · Cited by 122
Lander, V. E., Belle, J. I., Kingston, N. L., Herndon, J. M., Hogg, G. D., Liu, X., Kang, L.-I., Knolhoff, B. L., Bogner, S. J., Baer, J. M., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0192 · Cited by 114
Krisnawan, V. E., Stanley, J. A., Schwarz, J. K., & DeNardo, D. G. (2020) · Cancers · doi:10.3390/cancers12102916 · Cited by 114
Expression of Integrin αvβ6 and TGF-β in Scarless vs Scar-forming Wound Healing
Eslami, A., Gallant‐Behm, C. L., Hart, D. A., Wiebe, C., Honardoust, D., Gardner, H., Häkkinen, L., & Larjava, H. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.952572 · Cited by 118
Giacomini, M. M., Travis, M. A., Kudo, M., & Sheppard, D. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.01.020 · Cited by 109
Biological Significance of Local TGF-β Activation in Liver Diseases
Hayashi, H., & Sakai, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00012 · Cited by 121
Future treatments in systemic sclerosis
Asano, Y. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00758.x · Cited by 103
Fibrogenic Reactions in Lung Disease
Araya, J., & Nishimura, S. L. (2010) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092217 · Cited by 109
Varga, J., & Pasche, B. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32830e48e8 · Cited by 107
αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease
Saini, G., Porte, J., Weinreb, P. H., Violette, S. M., Wallace, W. A., McKeever, T. M., & Jenkins, G. (2015) · European Respiratory Journal · doi:10.1183/09031936.00210414 · Cited by 106
Self-citationThe Cellular and Molecular Mechanism of Radiation-Induced Lung Injury
Huang, Y., Zhang, W., Yu, F., & Gao, F. (2017) · Medical Science Monitor · doi:10.12659/msm.902353 · Cited by 107
TGF-β: Titan of Lung Fibrogenesis.
Yue, X., Shan, B., & Lasky, J. A. (2010) · PubMed · doi:10.2174/10067 · Cited by 105
Raghu, G., Mouded, M., Chambers, D. C., Martínez, F. J., Richeldi, L., LANCASTER, L. H., Hamblin, M. J., Gibson, K. F., Rosas, I. O., Prasse, A., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2824oc · Cited by 102
Self-citationJackson, I. L., Vujašković, Ž., & Down, J. D. (2009) · Radiation Research · doi:10.1667/rr1911.1 · Cited by 101
Dong, C., Góngora, R., Sosulski, M. L., Luo, F., & Sánchez, C. G. (2016) · Respiratory Research · doi:10.1186/s12931-016-0320-0 · Cited by 103
Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis
Dadrich, M., Nicolay, N. H., Flechsig, P., Bickelhaupt, S., Hoeltgen, L., Roeder, F., Hauser, K., Tietz, A., Jenne, J., Perez, R. L., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1123366 · Cited by 100
Advances in pathogenic mechanisms and management of radiation-induced fibrosis
Wang, B., Wei, J., Meng, L., Wang, H., Qu, C., Chen, X., Xin, Y., & Jiang, X. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109560 · Cited by 100
Advances in Molecular Mechanisms and Treatment of Radiation-Induced Pulmonary Fibrosis
Chen, Z., Wu, Z., & Ning, W. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.09.009 · Cited by 96
Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses
Forbes, B., O’Lone, R. B., Pribul, P. K., Cahn, A. P., Clarke, C. J., Collinge, M., Dailey, L. A., Donnelly, L., Dybowski, J. A., Hassall, D. G., et al. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.001 · Cited by 97
Kang, J. H., Jung, M., Choudhury, M., & Leof, E. B. (2019) · The FASEB Journal · doi:10.1096/fj.201902354r · Cited by 96
John, A. E., Luckett, J., Tatler, A. L., Awais, R. O., Desai, A., Habgood, A., Ludbrook, S. B., Blanchard, A. D., Perkins, A. C., Jenkins, G. R., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120592 · Cited by 93
Degryse, A. L., Tanjore, H., Xu, X. C., Polosukhin, V. V., Jones, B. R., Boomershine, C. S., Ortiz, C., Sherrill, T. P., McMahon, F. B., Gleaves, L. A., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00397.2010 · Cited by 91
Epigenetics in radiation-induced fibrosis
Weigel, C., Schmezer, P., Plass, C., & Popanda, O. (2014) · Oncogene · doi:10.1038/onc.2014.145 · Cited by 91
Eberlein, C. A., Kendrew, J., McDaid, K., Alfred, A., Kang, J., Jacobs, V. N., Ross, S. J., Rooney, C., Smith, N. R., Rinkenberger, J. L., et al. (2012) · Oncogene · doi:10.1038/onc.2012.460 · Cited by 87
Li, Y., Fan, W., Link, F., Wang, S., & Dooley, S. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100397 · Cited by 90
Myofibroblast Differentiation and Enhanced Tgf-B Signaling in Cystic Fibrosis Lung Disease
Harris, W. T., Kelly, D. R., Zhou, Y., Wang, D., MacEwen, M. W., Hagood, J. S., Clancy, J. P., Ambalavanan, N., & Sorscher, E. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070196 · Cited by 86
Yang, J., Velikoff, M., CANALIS, E. M., Horowitz, J. C., & Kim, K. K. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00243.2013 · Cited by 85
Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis
Shea, B. S., Probst, C. K., Brazee, P. L., Rotile, N. J., Blasi, F., Weinreb, P. H., Black, K. E., Sosnovik, D. E., Cott, E. M. V., Violette, S. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.86608 · Cited by 84
Self-citationBeyond the Matrix: The Many Non-ECM Ligands for Integrins
LaFoya, B., Munroe, J. A., Miyamoto, A., Detweiler, M., Crow, J. J., Gazdik, T. R., & Albig, A. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020449 · Cited by 84
Sheppard, D. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201406-245mg · Cited by 82
Locally Advanced Non-small Cell Lung Cancer: The Past, Present, and Future
Govindan, R., Bogart, J. A., & Vokes, E. E. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318180270b · Cited by 78
Vittal, R., Mickler, E. A., Fisher, A. J., Zhang, C., Rothhaar, K., Gu, H., Brown, K. M., Emtiazdjoo, A., Lott, J. M., Frye, S. B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076451 · Cited by 77
Hove, I. V., Hu, T., Beets, K., Bergen, T. V., Etienne, I., Stitt, A. W., Vermassen, E., & Feyen, J. H. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100966 · Cited by 79
Jackson, I. L., Vujašković, Ž., & Down, J. D. (2011) · Radiation Research · doi:10.1667/rr2421.1 · Cited by 73
Current and novel drug therapies for idiopathic pulmonary fibrosis
Maher, T. M., & Adamali, H. I. (2012) · Drug Design Development and Therapy · doi:10.2147/dddt.s29928 · Cited by 75
Integrins and cadherins as therapeutic targets in fibrosis
Agarwal, S. K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00131 · Cited by 75
Terai, S., & Tsuchiya, A. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1258-1 · Cited by 71
Immunoglobulin light chains generate proinflammatory and profibrotic kidney injury
Ying, W., Li, X., Rangarajan, S., Feng, W., Curtis, L. M., & Sanders, P. W. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125517 · Cited by 68
Latella, G., & Rieder, F. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000363 · Cited by 72
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 60
Plaas, A., Velasco, J., Gorski, D. J., Li, J., Cole, A. A., Christopherson, K. W., & Sandy, J. D. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.05.003 · Cited by 60
Eberlein, C. A., Rooney, C., Ross, S. J., Farren, M. R., Weir, H. M., & Barry, S. T. (2014) · Oncogene · doi:10.1038/onc.2013.600 · Cited by 60
Li, H., Zheng, J., Fan, H., Li, H., Gao, Z., & Chen, D. (2013) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12044 · Cited by 58
The αvβ6 integrin in cancer cell‐derived small extracellular vesicles enhances angiogenesis
Krishn, S. R., Salem, I., Quaglia, F., Naranjo, N. M., Agarwal, E., Liu, Q., Sarker, S., Kopenhaver, J. S., McCue, P. A., Weinreb, P. H., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1763594 · Cited by 58
Self-citationIntegrins: An Important Link between Angiogenesis, Inflammation and Eye Diseases
Mrugacz, M., Bryl, A., Falkowski, M., & Zorena, K. (2021) · Cells · doi:10.3390/cells10071703 · Cited by 57
Loss of Matrix Metalloproteinase-13 Attenuates Murine Radiation-Induced Pulmonary Fibrosis
Flechsig, P., Hartenstein, B., Teurich, S., Dadrich, M., Hauser, K., Abdollahi, A., Gröne, H., Angel, P. E., & Huber, P. E. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.043 · Cited by 55
Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis
Madala, S. K., Korfhagen, T. R., Schmidt, S., Davidson, C. R., Edukulla, R., Ikegami, M., Violette, S. M., Weinreb, P. H., Sheppard, D., & Hardie, W. D. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00357.2013 · Cited by 52
Self-citationKriete, A., Mayo, K. L., Yalamanchili, N., Beggs, W. R., Bender, P. K., Kari, C., & Rodeck, U. (2008) · Immunity & Ageing · doi:10.1186/1742-4933-5-5 · Cited by 54
Tomos, I. P., Tzouvelekis, A., Aidinis, V., Manali, E. D., Bouros, E., Bouros, D. E., & Papiris, S. A. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1300533 · Cited by 52
Wang, B., Liu, W., Liu, C., Du, K., Guo, Z., Zhang, G., Huang, Z., Lin, S., Cen, B., Tian, Y., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.12.029 · Cited by 54
Tissue and matrix influences on airway smooth muscle function
Burgess, J. K., Ceresa, C., Johnson, S. R., Kanabar, V., Moir, L. M., Nguyen, T. T. B., Oliver, B. G. G., Schuliga, M. J., & Ward, J. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.12.007 · Cited by 52
Metadata
- Authors
- Puthawala, K., Hadjiangelis, N., Jacoby, S. C., Bayongan, E., Zhao, Z., Yang, Z., Devitt, M. L., Horan, G. S., Weinreb, P. H., Lukashev, M. E., Violette, S. M., Grant, K. S., Colarossi, C., Formenti, S. C., & Munger, J. S.
- Affiliations
- York University (US)
- Departments of Medicine
- Cell Biology, and
- New York University (US)
- Biogen (United States) (US)
- Corresponding author
- Munger, John S.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-01
- Volume
- 177
- Issue
- 1
- Pages
- 82-90
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC2176115
- OpenAlex
- W2155139007
- Cited by
- 272
- References
- 45
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 13 · 2023: 12 · 2022: 15 · 2021: 15 · 2020: 14 · 2019: 7 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 30 · 2013: 16 · 2012: 18
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Biogen
- National Institutes of Health (5r01hl077526-04)
- National Heart, Lung, and Blood Institute (HL063786, HL077526, R01HL063786)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- radiation-induced pulmonary fibrosis, TGF-beta activation, radiation-induced mortality, lung inflammation, antifibrotic therapy, alveolar epithelium
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Neoplasm, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Gene Expression Regulation, Haplotypes, Heterozygote, Mice, Inbred C57BL, Pulmonary Alveoli, Pulmonary Fibrosis, Signal Transduction, Integrins, Transforming Growth Factor beta, Radiation Pneumonitis, Mice, Knockout, Mice, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
